FLT3 plays an important role in maintaining the survival of normal HSCs [108] and is also expressed in the vast majority of AML cells along with its recurrent mutations (e.g., internal tandem duplication (ITD) and tyrosine kinase domain mutation (TKD)) [109]. Here, FLT3 is linked to acute myeloid leukemia.